A. Swaak

发表

Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus.

J. Nossent, A. Swaak, 1991, The Quarterly journal of medicine.

Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients.

C. Baltus, A. Swaak, G. Vreugdenhil, 1990, British journal of rheumatology.

The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis

A. Swaak, G. Vreugdenhil, Ph.D. A. J. G. Swaak M.D., 1990, Clinical Rheumatology.

Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis

H. G. Eijk, A. Swaak, R. Feelders, 1992, Annals of Hematology.

Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment

A. Swaak, G. Vreugdenhil, 2004, Rheumatology International.

Transferrin microheterogeneity in rheumatoid arthritis

H. G. Eijk, A. Swaak, R. Feelders, 1992, Rheumatology International.

Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset.

M. Jongen‐Lavrencic, F. Breedveld, A. Swaak, 1996, Annals of the rheumatic diseases.

Iron repletion as a contribution to erythropoietin treatment of anemia in rheumatoid arthritis: To the Editor:

H. G. Eijk, A. Swaak, R. Feelders, 1991 .

Iron repletion as a contribution to erythropoietin treatment of anemia in rheumatoid arthritis.

A. Swaak, G. Vreugdenhil, H. G. van Eijk, 1991, The American journal of medicine.

Psychiatric symptoms before systemic lupus erythematosus is diagnosed

A. Swaak, T. Feltkamp, R. Smeenk, 2004, Rheumatology International.

Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

M. Jongen‐Lavrencic, A. Swaak, G. Vreugdenhil, 1996, Annals of the rheumatic diseases.

Pancytopenia in systemic lupus erythematosus related to azathioprine

J. Nossent, A. Swaak, 1990, Journal of internal medicine.

W S PhD thesis Polymorphism of HLA class II alleles and tumor necrosis factor alpha promoter alleles in Hungarian patients with systemic lupus erythematosus and with primary Sjogren's syndrome

L. Kovács, L. Berek, H. Chwalińska-Sadowska, 2019 .

Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis

B. Löwenberg, H. G. Eijk, A. Swaak, 1992, European journal of clinical investigation.

Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients.

J. Romijn, A. Eggermont, A. Eggermont, 1999, Metabolism: clinical and experimental.

IL‐6‐induced anaemia in rats: possible pathogenetic implications for anaemia observed in chronic inflammations

P. H. Cox, F. Breedveld, M. Jongen‐Lavrencic, 1996, Clinical and experimental immunology.

Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid.

A. Swaak, J. Koster, P. Biemond, 1984, Arthritis and rheumatism.

Cognitive and emotional disturbances in systemic lupus erythematosus.

J. Nossent, A. Swaak, A. V. van Dam, 1991, Psychotherapy and psychosomatics.

Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease

M. Jongen‐Lavrencic, A. Swaak, G. Vreugdenhil, 1995, Clinical Rheumatology.

R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis

M. Jongen‐Lavrencic, I. Touw, A. Swaak, 1994, Rheumatology International.

counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis

M. Jongen‐Lavrencic, I. Touw, A. Swaak, 1994 .

Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

F. V. D. van den Hoogen, L. van de Putte, H. V. van Lier, 1996, British journal of rheumatology.

Intracellular and extracellular sulphydryl levels in rheumatoid arthritis.

A. Swaak, J. Koster, P. Biemond, 1986, Annals of the rheumatic diseases.

Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders

A. Swaak, G. Vreugdenhil, C. Nieuwenhuizen, 1992, European journal of haematology.

Impaired erythropoietin responsiveness to the anaemia in rheumatoid arthritis. A possible inverse relationship with iron stores and effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

A. Swaak, G. Vreugdenhil, H. G. van Eijk, 1991, Clinical and experimental rheumatology.

Diminished superoxide production of synovial fluid neutrophils in patients with rheumatoid arthritis following piroxicam treatment.

A. Swaak, J. Koster, P. Biemond, 1990, Scandinavian journal of rheumatology.

Covalent cross-links in oxygen free radical altered human immunoglobulin G.

A. Swaak, C. E. Hack, H. G. van Eijk, 1988, Scandinavian journal of rheumatology. Supplement.

Superoxide production bypolymorphonuclear leucocytes inrheumatoid arthritis andosteoarthritis: invivoinhibition bytheantirheumatic drugpiroxicam duetointerference withtheactivation ofthe NADPH-oxidase

A. Swaak, J. Koster, P. Biemond, 1986 .

Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome

A. Swaak, J. Nossent, 1998, Lupus.

Interactions between oxygen free radicals and proteins. Implications for rheumatoid arthritis. An overview.

A. Swaak, C. E. Hack, J. Koster, 1989, Scandinavian journal of rheumatology.

Effect ofrecombinant humanerythropoietin on anaemia and diseaseactivity inpatients with rheumatoid arthritis andanaemia ofchronic disease: arandomised placebo controlled double blind 52weeksclinical trial

M. Jongen‐Lavrencic, A. Swaak, G. Vreugdenhil, 1996 .

Superoxide dependent iron release from ferritin in inflammatory diseases.

A. Swaak, H. G. van Eijk, A. Swaak, 1988, Free radical biology & medicine.

Intraarticular ferritin-bound iron in rheumatoid arthritis. A factor that increases oxygen free radical-induced tissue destruction.

A. Swaak, H. G. van Eijk, A. Swaak, 1986, Arthritis and rheumatism.

Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation.

A. Swaak, J. Koster, P. Biemond, 1986, The Biochemical journal.

Correlation of iron exchange between the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one(L1) and transferrin and possible antianaemic effects of L1 in rheumatoid arthritis.

A. Swaak, G. Vreugdenhil, H. G. van Eijk, 1990, Annals of the rheumatic diseases.

EFFICACY AND SAFETY OF ORAL IRON CHELATOR L1 IN ANAEMIC RHEUMATOID ARTHRITIS PATIENTS

H. G. Eijk, A. Swaak, G. Vreugdenhil, 1989, The Lancet.

Anaemia of chronic disease in rheumatoid arthritis

B. Löwenberg, H. G. Eijk, A. Swaak, 1990, Rheumatology International.

Prediction and evaluation of the effect of iron treatment in anaemic RA patients

H. G. Eijk, A. Swaak, G. Vreugdenhil, 1989, Clinical Rheumatology.

Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness.

A. Swaak, G. Vreugdenhil, H. G. van Eijk, 1990, Annals of the rheumatic diseases.

Elevated serum transcobalamin levels in anaemia of rheumatoid arthritis: correlation with disease activity but not with serum tumour necrosis factor alpha and interleukin 6

J. Lindemans, H. G. Eijk, A. Swaak, 1992, Journal of internal medicine.

Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases.

A. Swaak, H. G. van Eijk, A. Swaak, 1984, The Journal of clinical investigation.

Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures

M. Jongen‐Lavrencic, F. Breedveld, A. Swaak, 1999, Rheumatology International.

Anemia of chronic disease: a misnomer?

A. Swaak, G. Vreugdenhil, 1992, Annals of internal medicine.

Impaired iron uptake and transferrin binding by erythroblasts in the anaemia of rheumatoid arthritis.

B. Löwenberg, A. Swaak, G. Vreugdenhil, 1990, British journal of rheumatology.

Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis.

B. Löwenberg, A. Swaak, G. Vreugdenhil, 1990, Rheumatology international.

Daily stressors and systemic lupus erythematosus: a longitudinal analysis--first findings.

A. Vingerhoets, J. Nossent, A. Swaak, 1991, Psychotherapy and psychosomatics.

Profiles of the acute‐phase reactants C‐reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus

D. Hesselink, L. Aarden, A. Swaak, 2003, Scandinavian journal of rheumatology.

Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.

A. Swaak, J. Koster, P. Biemond, 1986, Annals of the rheumatic diseases.

Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease.

M. Jongen‐Lavrencic, F. Breedveld, A. Swaak, 1997, The Journal of rheumatology.

Common variable immunodeficiency in a patient with systemic lupus erythematosus

A. Swaak, HG van den Brink, 1996, Lupus.

Differential stimulation by oxygen-free-radical-altered immunoglobulin G of the production of superoxide and hydrogen peroxide by human polymorphonuclear leucocytes.

W. Sluiter, A. Swaak, C. E. Hack, 1991, Clinical science.

Pure red-cell aplasia in systemic lupus erythematosus.

J. Nossent, A. Swaak, 1988, Clinical Rheumatology.

Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus.

A. Hovestadt, J. Nossent, A. Swaak, 2010, Arthritis and rheumatism.

The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus.

M. Petri, C. Kallenberg, M. Bijl, 1998, Arthritis and rheumatism.

Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD)

A. Swaak, G. Vreugdenhil, C. Nieuwenhuizen, 1994, Clinical and experimental rheumatology.

No detection of macrophage erythropoietin production in bone marrow from rheumatoid arthritis patients with and without anaemia and controls

A. Swaak, G. Vreugdenhil, B. Lowenberg, 1991, Clinical Rheumatology.

DISEASE-ACTIVITY OF SLE DURING DIALYSIS AND AFTER RENAL-TRANSPLANTATION

A. Swaak, J. Nossent, J. Berden, 1990 .

Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease

M. Jongen‐Lavrencic, A. Swaak, G. Vreugdenhil, 1995, Clinical Rheumatology.

Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness.

A. Swaak, G. Vreugdenhil, A. Wognum, 1990, Annals of the rheumatic diseases.

Prognostic factors in systemic lupus erythematosus

J. Nossent, A. Swaak, A. Swaak, 2004, Rheumatology International.

Intestinal flora of patients with rheumatoid arthritis: induction of chronic arthritis in rats by cell wall fragments from isolated Eubacterium aerofaciens strains.

A. Swaak, M. Hazenberg, J. Kool, 1990, British journal of rheumatology.